ulcerative-colitis

Documents about ulcerative-colitis

• Image 2_Machine learning–driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.png#480326Figshare
• Table 3_Machine learning–driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.docx#480327Figshare
• Table 2_Machine learning–driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.docx#480328Figshare
• Image 3_Machine learning–driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.tif#480329Figshare
• Table 4_Machine learning–driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.docx#480330Figshare
• Magnesium in Gastrointestinal Disease#832943ClinicalTrials.gov
• Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio#828137ClinicalTrials.gov
• Adalimumab in the Treatment of Chronic Pouchitis#833853ClinicalTrials.gov
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.#836666ClinicalTrials.gov
• Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients#886394ClinicalTrials.gov
• The Nori Health App#890919ClinicalTrials.gov
• Development of 'Emma'--a Pediatric IBD Quiz#904190ClinicalTrials.gov
• A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies#1045103ClinicalTrials.gov
• The evaluation of motor deficits in children with ulcerative colitis: a cross-sectional study.#156801NCBI PubMed Central
• Data Management and Sharing Plan for: SBIR: Development of IMYX-3 for the Treatment of Ulcerative Colitis#219945UNC Dataverse Dataverse OAI Archive
• Efficacy of Probiotics in Patients With IBD#234449ClinicalTrials.gov
• Fecal microbiota transplantation in ulcerative colitis: mucosal immune mechanisms and precision microbiota therapy.#427712NCBI PubMed Central
• Artificial Intelligence Analysis of Ulcerative Colitis Using an Autoimmune Discovery Transcriptomic Panel#478130CiNii
• Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis.#625950NCBI PubMed Central
• Tracking Biologics Along the Silk Road#839934ClinicalTrials.gov
• The NOR-SWITCH Study#847677ClinicalTrials.gov
• SMART-IBD App Trial#862212ClinicalTrials.gov
• Locus of Control in Patients with Mild-to-Moderate Ulcerative Colitis: A Comparative Study#1067628PubMed Central
• Latent profiles of self-management behavior and associated factors among Chinese patients with ulcerative colitis.#152172NCBI PubMed Central
• Identification and Analysis of Biomarkers Associated With Lipid Metabolism and Ferroptosis in Ulcerative Colitis.#182380NCBI PubMed Central
• NORDTREAT Prospective Study on Inflammatory Bowel Disease#314348ClinicalTrials.gov
• Multistrain Probiotics Reduces UC Depression and Anxiety Scores#834962ClinicalTrials.gov
• MRI Anastomotic Integrity of Pelvic Intestinal Anastomoses#836767ClinicalTrials.gov
• Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)#837167ClinicalTrials.gov
• Quality of Life for Patients With Chronic Paediatric Onset Inflammatory Bowel Disease (IBD)#861577ClinicalTrials.gov
• QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)#894804ClinicalTrials.gov
• Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation#908654ClinicalTrials.gov
• Enabling Microbiomics- Driven Personalized Nutrition#916640ClinicalTrials.gov
• Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis#843325ClinicalTrials.gov
• Additional Crypt Phenotypes Lined With High-Grade Cellular Dysplasia in Protruding Growths in Ulcerative Colitis.#159739NCBI PubMed Central
• QiC3: A novel automated quantitative immunohistological disease activity index for ileocolonic Crohn's disease and ulcerative colitis#349782bioRxiv / medRxiv
• Short-chain fatty acids in ulcerative colitis: integrating metabolic fate, dynamic biomarkers, and precision delivery.#358261NCBI PubMed Central
• Inorganic nitrogen metabolic reprogramming of the gut microbiome drives fecal microbiota transplantation in ulcerative colitis.#381085NCBI PubMed Central
• Bowel Urgency in Ulcerative Colitis Is Common and Associated With Disability, With Mediation From Psychosocial Factors.#458526NCBI PubMed Central
• Dietary Impact on Intestinal Sulfate Metabolism#804074ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics of Oral NX-13 in Healthy Adults Male and Female Volunteers#808142ClinicalTrials.gov
• Predicting Biologic Therapy Success in Ulcerative Colitis Using Intestinal Ultrasound and Fat Assessment#835944ClinicalTrials.gov
• Managing Inflammatory Bowel Disease#838758ClinicalTrials.gov
• Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)#847628ClinicalTrials.gov
• Virtual Reality Headset and Acceptability of Rectosigmoidoscopy in Ulcerative Colitis: a Randomised Controlled Trial#850194ClinicalTrials.gov
• Curcumin in Pediatric Inflammatory Bowel Disease#854916ClinicalTrials.gov
• A Long-term Extension Study of Ustekinumab in Pediatric Participants#877479ClinicalTrials.gov
• Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease#1010637ClinicalTrials.gov
• Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease#1030030ClinicalTrials.gov
• Utility of Random Biopsies in Patients With Inflammatory Bowel Disease#158119ClinicalTrials.gov